MARKET

TENX

TENX

Tenax Therapeutics Inc
NASDAQ
3.960
+0.010
+0.25%
Opening 10:35 02/27 EST
OPEN
3.900
PREV CLOSE
3.950
HIGH
3.980
LOW
3.900
VOLUME
13.17K
TURNOVER
0
52 WEEK HIGH
64.40
52 WEEK LOW
3.770
MARKET CAP
6.99M
P/E (TTM)
-0.0324
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TENX last week (0219-0223)?
Weekly Report · 1d ago
Tenax Therapeutics Meets Nasdaq’s Float Requirement Compliance
TipRanks · 3d ago
Roth MKM Reiterates Buy on Tenax Therapeutics, Maintains $30 Price Target
Benzinga · 6d ago
Tenax Therapeutics Amends Global Rights Deal with Orion
TipRanks · 02/20 13:42
Weekly Report: what happened at TENX last week (0212-0216)?
Weekly Report · 02/19 09:42
Tenax Therapeutics 13G Filing Shows CVI Investments, Inc. Reported A 9.9% Stake In The Co As Of February 8, 2024
Benzinga · 02/16 17:45
Tenax Therapeutics Raises $9M in Public Offering and Warrants
TipRanks · 02/12 22:04
Weekly Report: what happened at TENX last week (0205-0209)?
Weekly Report · 02/12 09:38
More
About TENX
Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The Company's products include TNX-201 (oral enteric coated imatinib) and TNX-103 (oral levosimendan). The Company is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). It has the rights to develop and commercialize IV (TNX-101), subcutaneous (TNX-102), and oral (TNX-103) formulations of levosimendan. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. The Company has completed the Phase II trial of levosimendan in patients with PH and heart failure with preserved ejection fraction (HFpEF).

Webull offers Tenax Therapeutics Inc stock information, including NASDAQ: TENX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TENX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TENX stock methods without spending real money on the virtual paper trading platform.